0001209191-22-007263.txt : 20220204
0001209191-22-007263.hdr.sgml : 20220204
20220204172359
ACCESSION NUMBER: 0001209191-22-007263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Onofrio Matthew J
CENTRAL INDEX KEY: 0001578770
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36075
FILM NUMBER: 22594649
MAIL ADDRESS:
STREET 1: C/O EVOKE PHARMA, INC.
STREET 2: 505 LOMAS SANTA FE DRIVE
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evoke Pharma Inc
CENTRAL INDEX KEY: 0001403708
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208447886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: 858-345-1494
MAIL ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-02
0
0001403708
Evoke Pharma Inc
EVOK
0001578770
D'Onofrio Matthew J
C/O EVOKE PHARMA, INC.
420 STEVENS AVENUE, SUITE 370
SOLANA BEACH
CA
92075
0
1
0
0
Exec VP, Chief Bus. Officer
Stock Option (Right to Buy)
0.55
2022-02-02
4
A
0
100000
0.00
A
2032-02-01
Common Stock
100000
100000
D
The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2022, subject to the reporting person's continuous service to the issuer on each such vesting date.
/s/ Matthew J. D'Onofrio
2022-02-04